Highly efficient delivery of a large therapeutic mass aerosol

Details Highly efficient delivery of a large therapeutic mass aerosol Highly efficient delivery of a large therapeutic mass aerosol

2005-07-26

2005-07-26

Kunz, Gary (Department: 1616)

Drug, bio-affecting and body treating compositions

Effervescent or pressurized fluid containing

Organic pressurized fluid

C424S046000, C424S489000, C424S499000, C424S434000, C514S002600, C514S003100

Reexamination Certificate

active

06921528

ABSTRACT:
A method for delivering a therapeutic dose of a bioactive agent to the pulmonary system, in a single, breath-activated step, comprises administering from a receptacle enclosing a mass of particles, to a subject's respiratory tract, particles which have a tap density of less than 0.4 g/cm3and deliver at least about 50% of the mass of particles. Another method of delivering a therapeutic dose of a bioactive agent to the pulmonary system, in a single breath, includes administering from a receptacle enclosing a mass of particles, to a subject's respiratory tract, particles which have a tap density of at least 0.4 g/cm3and deliver at least about 10 milligrams of the bioactive agent. The receptacle can have a volume of at least 0.37 cm3.

REFERENCES:
patent: 4069819 (1978-01-01), Valentini et al.
patent: 4995385 (1991-02-01), Valentini et al.
patent: 5260306 (1993-11-01), Boardman et al.
patent: 5304125 (1994-04-01), Leith
patent: 5306483 (1994-04-01), Mautone
patent: 5506203 (1996-04-01), Bäckström et al.
patent: 5518998 (1996-05-01), Bäckström et al.
patent: 5641510 (1997-06-01), Clark et al.
patent: 5642728 (1997-07-01), Andersson et al.
patent: 5795594 (1998-08-01), York et al.
patent: 5830853 (1998-11-01), Bäckström et al.
patent: 5851453 (1998-12-01), Hanna et al.
patent: 5855913 (1999-01-01), Hanes et al.
patent: 5874064 (1999-02-01), Edwards et al.
patent: 5985309 (1999-11-01), Edwards et al.
patent: 5993805 (1999-11-01), Sutton et al.
patent: 5997848 (1999-12-01), Patton et al.
patent: 6019968 (2000-02-01), Platz et al.
patent: 6051256 (2000-04-01), Platz et al.
patent: 6063138 (2000-05-01), Hanna et al.
patent: 6136295 (2000-10-01), Edwards et al.
patent: 6165463 (2000-12-01), Platz et al.
patent: RE37053 (2001-02-01), Hanes et al.
patent: 6254854 (2001-07-01), Edwards et al.
patent: 6284282 (2001-09-01), Maa et al.
patent: 6372258 (2002-04-01), Platz et al.
patent: 6399102 (2002-06-01), Edwards et al.
patent: 6423344 (2002-07-01), Platz et al.
patent: 6436443 (2002-08-01), Edwards et al.
patent: 6447752 (2002-09-01), Edwards et al.
patent: 6447753 (2002-09-01), Edwards et al.
patent: 6503480 (2003-01-01), Edwards et al.
patent: 6652837 (2003-11-01), Edwards et al.
patent: WO 95/00127 (1995-01-01), None
patent: WO 96/09814 (1996-04-01), None
patent: WO 96/32096 (1996-10-01), None
patent: WO 96/32149 (1996-10-01), None
patent: WO 97/44013 (1997-11-01), None
patent: WO 98/16205 (1998-04-01), None
patent: WO 98/17257 (1998-04-01), None
patent: WO 98/31346 (1998-07-01), None
patent: WO 99/16419 (1999-04-01), None
patent: WO 99/66903 (1999-12-01), None
patent: WO 00/10541 (2000-03-01), None
patent: WO 00/33811 (2000-06-01), None
patent: WO 01/13893 (2001-03-01), None
patent: WO 01/51030 (2001-07-01), None
Hanes, J., et al., “Porous Dry-Powder PLGA Microspheres Coated with Lung Surfactant Forsystemic Insulin Delivery Via the Lung,”Controlled Release Soc.,24:57-58.
Edwards, David A., et al. “Large Porous Aerosols for Pulmonary Drug Delivery,”Proc. Int. Symp. Controlled Release Bioact. Mater.,24:67-68 (1997).
Anderson, S.D. et al., “A New Method for Bronchial-Provocation Testing in Asthmatic Subjects Using a Dry Powder of Mannitol,”Am. J. Respir. Crit. Care Med. 156:758-765 (1997).
Anderson, S.D. et al., “The Effect of Inhaling a Dry Powder of Sodium Chloride on the Airways of Asthmatic Subjects,”Eur. Respir. J. 10:2465-2476 (1997).
Ben-Jebria, A. et al., “Large Porous Particles for Sustained Protection from Carbachol-Induced Bronchoconstriction in Guinea Pigs,”Pharm. Res. 16(4):555-561 (1999).
Cipolla, D. et al., “Bolus Administration of INS365: Studying the Feasibility of Delivering High Dose Drugs Using the AERx® Pulmonary Delivery System,”Respiratory Drug Delivery, VII:231-239 (2000).
Edwards, D.A., “The Macrotransport of Aerosol Particles in the Lung: Aerosol Deposition Phenomena,”J. Aerosol Sci., 26(2):293-317 (1995).
Edwards, D.A. et al., “Large Porous Particles for Pulmonary Drug Delivery,”Science 276:1868-71 (1997).
Huang, C-H. et al., “Calorimetric and Molecular Mechanics Studies of the Thermotropic Phase Behavior of Membrane Phospholipids,”Biochim. Biophys. Acta., 1422:273-307 (1999).
Pritchard, J.N. et al., “Use of In Vitro Particle Size Data to Predict Deposition and Effects of Inhaled Drugs,”International Conference on Aerosol Therapy.Italy, (Dec. 2-5, 1998).
Scheuch, G. et al., “Measuring in vivo deposition of large porous particles,”Journal of Aerosol Medicine 12(2):127-138 (1999).
Wang, J. et al., “Inhalation of Estradiol for Sustained Systemic Delivery,”Journal of Aerosol Medicine, 12(1):27-36 (1999).
Wolff, R.K., “Safety of Inhaled Proteins for Therapeutic Use,”Journal of Aerosol Medicine, 11(4):197-219 (1998).

Affiliated with

Also associated with

Rating

Highly efficient delivery of a large therapeutic mass aerosol does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Highly efficient delivery of a large therapeutic mass aerosol, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Highly efficient delivery of a large therapeutic mass aerosol will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3409110